Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 72, Issue 3, Pages 417-428Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-014-1752-7
Keywords
Biomarker; Pathway; Cancer; Treatment
Categories
Funding
- Hungarian Scientific Research Fund [OTKA K100295]
Ask authors/readers for more resources
Several lines of evidence support the relevance of microRNAs in both adrenocortical and adrenomedullary (pheochromocytomas) tumors. Significantly differentially expressed microRNAs have been described among benign and malignant adrenocortical tumors and different forms of pheochromocytomas that might affect different pathogenic pathways. MicroRNAs can be exploited as markers of malignancy or disease recurrence. Besides tissue microRNAs, novel data show that microRNAs are released in body fluids, and blood-borne microRNAs can be envisaged as minimally invasive markers of malignancy or prognosis. MicroRNAs might even serve as treatment targets that could expand the rather-limited therapeutic repertoire in the field of adrenal tumors. In this review, we present a critical synopsis of the recent observations made in the field of adrenal tumor-associated microRNAs regarding their pathogenic, diagnostic, and potential therapeutic relevance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available